ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $886,000 | +42.7% | 9,528 | -8.6% | 0.03% | +27.3% |
| Q3 2021 | $621,000 | +37.1% | 10,423 | +56.8% | 0.02% | +57.1% |
| Q2 2021 | $453,000 | -74.7% | 6,648 | -74.2% | 0.01% | -77.0% |
| Q1 2021 | $1,789,000 | -13.5% | 25,781 | -4.2% | 0.06% | -11.6% |
| Q4 2020 | $2,069,000 | -0.1% | 26,925 | -2.8% | 0.07% | -10.4% |
| Q3 2020 | $2,072,000 | +14.6% | 27,708 | -3.6% | 0.08% | +11.6% |
| Q2 2020 | $1,808,000 | +23.0% | 28,728 | -17.9% | 0.07% | +19.0% |
| Q1 2020 | $1,470,000 | +11.3% | 34,996 | +20.3% | 0.06% | +34.9% |
| Q4 2019 | $1,321,000 | – | 29,079 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |